Company Quick10K Filing
Novo Integrated Sciences
10-Q 2020-11-30 Filed 2021-01-13
10-K 2020-08-31 Filed 2020-12-09
10-Q 2020-05-31 Filed 2020-07-14
10-Q 2020-02-29 Filed 2020-04-20
10-Q 2019-11-30 Filed 2020-01-13
10-K 2019-08-31 Filed 2019-11-20
10-Q 2019-05-31 Filed 2019-07-11
10-Q 2019-02-28 Filed 2019-04-11
10-Q 2018-11-30 Filed 2019-01-11
10-K 2018-08-31 Filed 2018-11-06
10-Q 2018-05-31 Filed 2018-07-11
10-Q 2018-02-28 Filed 2018-04-12
10-Q 2017-11-30 Filed 2018-01-12
10-K 2017-08-31 Filed 2017-12-08
10-Q 2017-05-31 Filed 2017-07-24
10-Q 2017-03-31 Filed 2017-04-14
10-K 2016-12-31 Filed 2017-03-07
10-Q 2016-09-30 Filed 2016-10-31
10-Q 2016-06-30 Filed 2016-07-22
10-Q 2016-03-31 Filed 2016-04-29
10-K 2015-12-31 Filed 2016-03-25
10-Q 2015-09-30 Filed 2015-10-30
10-Q 2015-06-30 Filed 2015-07-31
10-Q 2015-03-31 Filed 2015-05-01
10-K 2014-12-31 Filed 2015-03-27
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-19
10-K 2013-12-31 Filed 2014-04-16
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-16
10-Q 2013-03-31 Filed 2013-05-20
10-K 2012-12-31 Filed 2013-04-15
10-Q 2012-09-30 Filed 2012-11-23
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-06
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-03-31
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-14
8-K 2020-11-23
8-K 2020-11-09
8-K 2020-10-19
8-K 2020-08-06
8-K 2020-07-21
8-K 2020-04-07
8-K 2020-03-20
8-K 2020-03-09
8-K 2020-02-04
8-K 2019-12-17
8-K 2019-10-23
8-K 2019-09-24
8-K 2019-09-11
8-K 2019-03-06
8-K 2019-02-26
8-K 2019-02-20
8-K 2019-01-31
8-K 2019-01-14
8-K 2018-12-18
8-K 2018-11-30
8-K 2018-11-23
8-K 2018-11-14
8-K 2018-10-23
8-K 2018-10-17
8-K 2018-10-10
8-K 2018-07-27
8-K 2018-05-31
8-K 2018-04-08
8-K 2018-03-19
8-K 2018-03-15
8-K 2018-01-30
8-K 2018-01-16
8-K 2017-12-29
8-K 2017-12-26

Novo Integrated Sciences Financials

NVOS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash79121124625013120629891434171354151,6741,8971,2961,0378646769292,3742,478
Accounts Receivable8551,1291,2891,3491,3121,3381,4051,3791,383
Inventory
PP&E52517619701615147012109376001520571559609641729790800806
Assets17816426226275354922379358295201133232922222847312770375,3895,5144,9585,0724,8404,7435,06229,08131,682
Accounts Payable13411911675124118120163160146134161778310156121327932051,8951,7031,5751,7441,3101,3081,3681,2541,284
Long-Term Debt64968781377344611719224427230800004064284084114060000
Liabilities2,0582,2442,3542,0557978329749571,2631,3061,2211,34571464810156121327932059,9389,8039,3394,7194,5564,5704,5454,2526,368
Stockholders' Equity-1,879-2,080-2,328-1,829-522-797-925-935-884-948-925-1,145-580-626-73-3410152022245032-4,531-4,268-4,35837931020155124,86625,351
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue2,0902,2202,2542,3102,3232,3122,2002,490
Cost of Revenue1,3771,2551,4081,3381,4181,3381,4281,3211,557
Gross Profit713966846971905834884880933
R&D87043000000000000250000
SG&A9749281,0182,0101,0829271,099958996
Tax000000000
Net Income-485-501-417-409-199-165-243-283-169-192-146-327-209-328-2,360-362-13-35-68-17-37-42-37-357-616-357-1,375-218-158-251-120-99
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating-35-145-45-49-90-70-40-42-32-31-40-26-85-50-15-21-46-20-23-54-298-724-352-421-94-163-297-71
Cash Investing0-19800000000-100000-392-750-24-83-94-74-227-404
Cash Financing373422868657143512037383385502040301565152,1603,023-184-286114971,940639